Paola Bonsi

ORCID: 0000-0001-5940-9028
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroscience and Neuropharmacology Research
  • Neurological disorders and treatments
  • Genetic Neurodegenerative Diseases
  • Parkinson's Disease Mechanisms and Treatments
  • Receptor Mechanisms and Signaling
  • Ion channel regulation and function
  • Neuroscience and Neural Engineering
  • Neural dynamics and brain function
  • Autism Spectrum Disorder Research
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Nicotinic Acetylcholine Receptors Study
  • Neurotransmitter Receptor Influence on Behavior
  • Botulinum Toxin and Related Neurological Disorders
  • Memory and Neural Mechanisms
  • Photoreceptor and optogenetics research
  • RNA regulation and disease
  • Phosphodiesterase function and regulation
  • Nuclear Receptors and Signaling
  • Transcranial Magnetic Stimulation Studies
  • Cell death mechanisms and regulation
  • Nitric Oxide and Endothelin Effects
  • Epilepsy research and treatment
  • Metabolism and Genetic Disorders
  • Pain Mechanisms and Treatments

Fondazione Santa Lucia
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2014-2024

University of Pavia
2021

University of Rome Tor Vergata
2000-2013

European Brain Research Institute
2006-2007

Istituto Superiore di Sanità
1999-2002

Novem (Netherlands)
2002

Sapienza University of Rome
1994-1999

Parkinson's disease (PD) is characterized by the selective vulnerability of nigrostriatal dopaminergic circuit. Recently, loss-of-function mutations in PTEN-induced kinase 1 (PINK1) gene have been linked to early-onset PD. How PINK1 deficiency causes dysfunction and degeneration PD patients unknown. Here, we investigate physiological role circuit through generation multidisciplinary analysis PINK1(-/-) mutant mice. We found that numbers neurons levels striatal dopamine (DA) DA receptors are...

10.1073/pnas.0702717104 article EN Proceedings of the National Academy of Sciences 2007-06-12

DYT1 dystonia is a severe form of inherited dystonia, characterized by involuntary twisting movements and abnormal postures. It linked to deletion in the dyt1 gene, resulting mutated protein torsinA. The penetrance for incomplete, but both clinically affected non-manifesting carriers mutation exhibit impaired motor learning evidence altered plasticity. Here, we striatal glutamatergic synaptic plasticity transgenic mice expressing either normal human torsinA or its mutant form, comparison...

10.1093/brain/awp194 article EN Brain 2009-07-29

Work over the past two decades revealed a previously unexpected role for striatal cholinergic interneurons in context of basal ganglia function. The recognition that these are essential synaptic plasticity and motor learning represents significant step ahead deciphering how striatum processes cortical inputs, why pathological circumstances cause dysfunction. Loss reciprocal modulation between dopaminergic inputs intrinsic innervation within appears to be trigger pathophysiological changes...

10.3389/fnana.2011.00006 article EN cc-by Frontiers in Neuroanatomy 2011-01-01

Cortical spreading depression (CSD) is a key pathogenetic step in migraine with aura. Dysfunctions of voltage-dependent and receptor-operated channels have been implicated the generation CSD pathophysiology migraine. Although known correlation exists between release calcitonin gene-related peptide (CGRP), possibility that CGRP involved has not examined detail. We analyzed pharmacological mechanisms underlying investigated endogenous contributes to this phenomenon. was rat neocortical slices...

10.1073/pnas.1215435109 article EN Proceedings of the National Academy of Sciences 2012-10-29

The onset of abnormal movements in DYT1 dystonia is between childhood and adolescence, although it unclear why clinical manifestations appear during this developmental period. Plasticity at corticostriatal synapses critically involved motor memory. In the Tor1a+/Δgag mouse model, long-term potentiation (LTP) appeared prematurely a critical window striatal spiny neurons (SPNs), while depression (LTD) was never recorded. Analysis dendritic spines showed an increase both spine width mature...

10.7554/elife.33331 article EN cc-by eLife 2018-03-05

Dopamine (DA) plays a crucial role in the modulation of striatal function. Striatal cholinergic interneurons represent an important synaptic target dopaminergic fibers arising from substantia nigra and cortical glutamatergic inputs. By means electrophysiological approach corticostriatal slices, we isolated three distinct inputs to interneurons: glutamate-mediated EPSPs, GABAA-mediated potentials, Acetylcholine (ACh)-mediated IPSPs. We therefore explored whether DA controls activity through...

10.1523/jneurosci.20-07-j0003.2000 article EN cc-by-nc-sa Journal of Neuroscience 2000-04-01

Abnormal involuntary movements and cognitive impairment represent the classical clinical symptoms of Huntington's disease (HD). This genetic disorder involves degeneration striatal spiny neurons, but not large cholinergic interneurons, corresponds to a marked decrease in activity mitochondrial complex II [succinate dehydrogenase (SD)] brains HD patients. Here we have examined possibility that SD inhibitors exert their toxic action by increasing glutamatergic transmission. We report such as...

10.1523/jneurosci.21-14-05110.2001 article EN cc-by-nc-sa Journal of Neuroscience 2001-07-15

Summary: Purpose: Alterations in neuronal calcium (Ca 2+ ) homeostasis are believed to play an essential role the generation and propagation of epileptiform events. Levetiracetam (LEV) lamotrigine (LTG), novel antiepileptic drugs (AEDs), were tested on events corresponding elevations intracellular Ca concentration ([Ca ] i recorded from rat neocortical slices. Methods: Electrophysiological recordings performed single pyramidal neurons a slice preparation. Spontaneous consisting long‐lasting,...

10.1111/j.0013-9580.2004.02204.x article EN Epilepsia 2004-06-28

Projections from thalamic intralaminar nuclei convey sensory signals to striatal cholinergic interneurons. These neurons respond with a pause in their pacemaking activity, enabling synaptic integration cortical inputs medium spiny (MSNs), thus playing crucial role motor function. In mice the DYT1 dystonia mutation, stimulation of thalamostriatal axons, mimicking response salient events, evoked shortened and triggered an abnormal spiking activity This altered pattern caused significant...

10.1523/jneurosci.0041-12.2012 article EN cc-by-nc-sa Journal of Neuroscience 2012-08-29

Broad-spectrum muscarinic receptor antagonists have represented the first available treatment for different movement disorders such as dystonia. However, specificity of these drugs and their mechanism action is not entirely clear. We performed a systematic analysis effects anticholinergic on short- long-term plasticity recorded from striatal medium spiny neurons DYT1 dystonia knock-in (Tor1a(+/Δgag) ) mice heterozygous ΔE-torsinA controls (Tor1a(+/+) mice). Antagonists were chosen that had...

10.1002/mds.26009 article EN Movement Disorders 2014-09-04

Muscarinic autoreceptors regulate cholinergic tone in the striatum. We investigated functional consequences of genetic deletion striatal muscarinic by means electrophysiological recordings from either medium spiny neurons (MSNs) or interneurons (ChIs) slices single M<sub>4</sub> double M<sub>2</sub>/M<sub>4</sub> acetylcholine receptor (mAChR) knock-out (−/−) mice. In control ChIs, agonist oxotremorine (300 nm) produced a self-inhibitory outward current that was mostly reduced...

10.1523/jneurosci.1678-08.2008 article EN Journal of Neuroscience 2008-06-11
Coming Soon ...